BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29465713)

  • 1. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.
    Roush GC; Abdelfattah R; Song S; Kostis JB; Ernst ME; Sica DA
    J Hypertens; 2018 Jun; 36(6):1247-1255. PubMed ID: 29465713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.
    Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB
    J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.
    Roush GC; Ernst ME; Kostis JB; Tandon S; Sica DA
    Hypertension; 2015 May; 65(5):1041-6. PubMed ID: 25733245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based diuretics: focus on chlorthalidone and indapamide.
    DiNicolantonio JJ; Bhutani J; Lavie CJ; O'Keefe JH
    Future Cardiol; 2015 Mar; 11(2):203-17. PubMed ID: 25760879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is chlorthalidone better than hydrochlorothiazide in reducing cardiovascular events in hypertensives?
    Roush GC; Buddharaju V; Ernst ME
    Curr Opin Cardiol; 2013 Jul; 28(4):426-32. PubMed ID: 23736816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
    Krum H; Skiba M; Gilbert RE
    Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.
    Roman MJ; Alderman MH; Pickering TG; Pini R; Keating JO; Sealey JE; Devereux RB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):387-96. PubMed ID: 9607375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial.
    Ernst ME; Neaton JD; Grimm RH; Collins G; Thomas W; Soliman EZ; Prineas RJ;
    Hypertension; 2011 Dec; 58(6):1001-7. PubMed ID: 22025372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrochlorothiazide versus chlorthalidone in the management of hypertension.
    Neff KM; Nawarskas JJ
    Cardiol Rev; 2010; 18(1):51-6. PubMed ID: 20010338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
    Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not just chlorthalidone: evidence-based, single tablet, diuretic alternatives to hydrochlorothiazide for hypertension.
    Roush GC; Ernst ME; Kostis JB; Kaur R; Sica DA
    Curr Hypertens Rep; 2015 Apr; 17(4):540. PubMed ID: 25821163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic.
    Vongpatanasin W
    Curr Opin Cardiol; 2015 Jul; 30(4):361-5. PubMed ID: 26049382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.